Brock Beauty Inc [2016] ATMO 44 (30 June 2016)
Brock Beauty applied for the extension of protection of its International Registration for BROCKBEAUTY covering cosmetic goods to Australia. The Australian Trade Marks Office objected to the extension of protection...
Brock Beauty applied for the extension of protection of its International Registration for BROCKBEAUTY covering cosmetic goods to Australia. The...
Read More
Codon-optimised nucleic acids remain patentable following Myriad
In a decision that issued on 5 July 2016 (“Cargill Incorporated v Dow AgroSciences LLC APO 43”), the Australian Patent Office confirmed that a nucleic acid that has...
In a decision that issued on 5 July 2016 (“Cargill Incorporated v Dow AgroSciences LLC APO 43”), the...
Read More
Throat Scope: Lighting Throats Around the World
lIt can be difficult for a doctor or parent to examine a child’s throat. If a wooden tongue depressor is used, with one hand the doctor or parent depresses...
lIt can be difficult for a doctor or parent to examine a child’s throat. If a wooden tongue depressor...
Read More
Scott-Dibben Pty Limited V Canterbury District Health Board [2016] ATMO 3
Scott-Dibben opposed the removal of its registration for HEALTHPATH; HEALTH PATHWAYS (a series mark) covering medical services in Class 44. The removal application was filed by Canterbury District Health...
Scott-Dibben opposed the removal of its registration for HEALTHPATH; HEALTH PATHWAYS (a series mark) covering medical services in Class...
Read More
Second Medical Use Claims in Australia
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein a known substance is to be used in a novel...
The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein...
Read More
Licensed and sublicensed to sue
This case provides some further interesting consideration of exclusive licences and consideration of the position of an exclusive sublicensee of a patent. Section 120 of the Patents Act 1990...
This case provides some further interesting consideration of exclusive licences and consideration of the position of an exclusive sublicensee...
Read More
Full Court finds that usual undertaking for damages is not limited by TG Act
The fact that the Therapeutic Goods Act 1989 contains provisions that permit the Commonwealth, among other parties, to recover compensation in certain pharmaceutical patent infringement proceedings does not preclude...
The fact that the Therapeutic Goods Act 1989 contains provisions that permit the Commonwealth, among other parties, to recover...
Read More